- Email: [email protected]
Beyond Gender: Ways Men and Women Cope With Illness and Grief
366
Schedule With Abstracts
provided in a setting that reflects the patient’s wishes. Quality indicators exist for structure-ofcare, process-of-care quality indicators, and outcome-of-care. One important outcome-of-care indicator is the appropriately timed cessation of chemotherapy. Chemotherapy cessation in the last 2 weeks of life is a benchmark for improving clinical practice in Quality Oncology Practice Initiative (QOPI) of the American Society of Clinical Oncology. Surveillance, Epidemiology, and End Results (SEER) data suggest that of those patients who received palliative chemotherapy, approximately 18.5% received chemotherapy in the last 2 weeks of life. This may be an underestimation. For the clinician, it is important to identify factors that lead to the continuation of chemotherapy late in a patient’s disease trajectory, as well as identify factors that should prompt a more detailed discussion as to why chemotherapy is being given. It is also important to understand when it is appropriate to give chemotherapy late in a disease trajectory. This session, lead by hematologists, oncologists, and nurses that have expertise in palliative care will focus on (a) when it is, and when it is not appropriate to give palliative chemotherapy, (b) treating physician, patient, and family issues related to therapy continuation; nursing experience with patients and families will be highlighted, (c) reviewing guidelines for the use of chemotherapy at the end-of-life, and (d) identifying ways the interdisciplinary teams can support physicians and patients in decision-making and communication; as well as engaging colleagues in implementing these guidelines. A guideline used to address these issues systematically in one cancer center will be described.
5e7:30 pm Poster Session and Job Fair in Exhibit Hall 5:30e6:30 pm AAHPM SIG Meetings Cancer Geriatrics Heart Failure Humanities and Spirituality Pediatrics HPNA Advanced Practice Nurse SIG Meeting
Vol. 43 No. 2 February 2012
Friday, March 9 7:15e8:15 am AAHPM SIG Meetings Education HIV Rural Developing Community: Social Workers HPNA Chapters Meetings 8e11:30 am Coffee With Exhibits and Posters 8:30e10 am
Plenary Session (102) Beyond Gender: Ways Men and Women Cope With Illness and Grief Kenneth J. Doka, PhD, The College of New Rochelle, New Rochelle, NY. (Doka has disclosed no relevant financial relationships.) Objectives 1. Describe institutional, intuitive, blended, and dissonant patterns of grief. 2. Discuss the ways that each pattern can facilitate or complicate the illness and grieving process. 3. Identify and discuss pathways to grieving patterns including, gender, culture, cohort, and temperament, 4. Describe interventive techniques suitable for each pattern. Many individuals believe that if an individual does not show or share sadness or express other emotions in coping with illness or loss, that individual is not in touch with or is suppressing emotion. In fact, grief reactions are highly individual and varied. Many men, and women, may express their grief in more instrumental ways, showing grief in more cognitive or active manifestations while others may use a more intuitive or emotion-based approach. This session explores the different patterns or styles of grief, as they are expressed in illness or loss, emphasizing that each of these pattern has their own distinct advantages and disadvantages.
Vol. 43 No. 2 February 2012
Schedule With Abstracts
Clinicians would benefit from this session in two major ways. First, it challenges clinicians to move beyond affect to explore the many ways that individuals cope with loss. Second, the presentation offers specific interventive strategies that are effective with different patterns.
Social Media ¼ Public Health Christian T. Sinclair, MD FAAHPM, Kansas City Hospice, Kansas City, MO. (Sinclair has disclosed no relevant financial relationships.) Objectives 1. Demonstrate the growth of social media as an effective health communication platform. 2. Recognize opportunities for professionals and organizations to efficiently incorporate social media as a public health education tool. By now you have heard so much about social media you are probably wondering when it might go away. While it may evolve and the latest platform of choice may change, the foundational aspects of social mediadincluding freedom of speech, cross-pollination of ideas, and ease of sharing across multiple media toolsdwill remain. These aspects make social media a great tool to help shape the public perception about hospice, palliative care, opioids, dying, grief, and many other aspects of our daily practice. Have you ever felt tired of educating by the ones? Well here is your chance to make a big difference. You will leave this session inspired to give it a try and talk to your colleagues and CEO about what you can do to use social media to improve public health.
10:45e11:45 am
Concurrent Sessions An Unlikely Union: Palliative Care and Wellness (400) Gregg VandeKieft, MD MA, Providence St. Peter Hospital, Olympia, WA. Rebecca Hawkins, ARNP, St. Mary Medical Center, Walla Walla, WA. Cobie Whitten, PhD, Providence Regional Cancer System, Olympia, WA. (All authors listed above for this session have disclosed no relevant financial relationships with the following exception: Hawkins is on
367
the speakers’ bureau and received an honorarium from Novartis, Amgen, and Oncology Nursing Society.) Objectives 1. Discuss the role of palliative care as a component of cancer survivorship and chronic disease management. 2. Describe a high functioning model of collaboration between palliative care teams, primary care clinicians, and subspecialists across the continuum of care for patients with cancer and other chronic illnesses. 3. List common conditions warranting palliative care in cancer survivors and in selected chronic diseases, along with appropriate therapies. Many clinicians equate palliative care with endof-life care and consult palliative care teams only after transitioning from ‘‘curative’’ therapies to end-of-life care. Recent literature demonstrates numerous advantages when cancer patients with advanced stage disease receive palliative care from the onset of cancer diagnosis and throughout their illness spectrum. Less attention has been paid to the palliative care needs of cancer survivors or patients with other chronic diseases in every stage of their illness. Using cancer survivorship as a model, this session will explore the role of palliative care in chronic disease more broadly. The presenters will outline how principles from cancer survivorship and palliative care can be integrated within the care of other chronic diseases, such as neurological disease, renal, lung, or cardiac disease. They will review palliative care needs and treatment options throughout the continuum of care in chronic illness, including cancer survivorship. Models of collaboration between diseaseoriented subspecialists, primary care clinicians, and palliative care teams will be highlighted, including strategies to facilitate optimal transition from ‘‘active treatment’’ by subspecialists back to longitudinal care by primary care clinicians with ongoing palliative care support. Common symptom complexes in cancer survivorship and chronic disease will be presented, along with interventions that palliative care teams can provide to support referring clinicians. The presenters include a palliative care physician with comprehensive primary care experience, a palliative care nurse practitioner with an extensive background in oncology nursing, and a psycho-oncologist specializing in cancer
Schedule With Abstracts
provided in a setting that reflects the patient’s wishes. Quality indicators exist for structure-ofcare, process-of-care quality indicators, and outcome-of-care. One important outcome-of-care indicator is the appropriately timed cessation of chemotherapy. Chemotherapy cessation in the last 2 weeks of life is a benchmark for improving clinical practice in Quality Oncology Practice Initiative (QOPI) of the American Society of Clinical Oncology. Surveillance, Epidemiology, and End Results (SEER) data suggest that of those patients who received palliative chemotherapy, approximately 18.5% received chemotherapy in the last 2 weeks of life. This may be an underestimation. For the clinician, it is important to identify factors that lead to the continuation of chemotherapy late in a patient’s disease trajectory, as well as identify factors that should prompt a more detailed discussion as to why chemotherapy is being given. It is also important to understand when it is appropriate to give chemotherapy late in a disease trajectory. This session, lead by hematologists, oncologists, and nurses that have expertise in palliative care will focus on (a) when it is, and when it is not appropriate to give palliative chemotherapy, (b) treating physician, patient, and family issues related to therapy continuation; nursing experience with patients and families will be highlighted, (c) reviewing guidelines for the use of chemotherapy at the end-of-life, and (d) identifying ways the interdisciplinary teams can support physicians and patients in decision-making and communication; as well as engaging colleagues in implementing these guidelines. A guideline used to address these issues systematically in one cancer center will be described.
5e7:30 pm Poster Session and Job Fair in Exhibit Hall 5:30e6:30 pm AAHPM SIG Meetings Cancer Geriatrics Heart Failure Humanities and Spirituality Pediatrics HPNA Advanced Practice Nurse SIG Meeting
Vol. 43 No. 2 February 2012
Friday, March 9 7:15e8:15 am AAHPM SIG Meetings Education HIV Rural Developing Community: Social Workers HPNA Chapters Meetings 8e11:30 am Coffee With Exhibits and Posters 8:30e10 am
Plenary Session (102) Beyond Gender: Ways Men and Women Cope With Illness and Grief Kenneth J. Doka, PhD, The College of New Rochelle, New Rochelle, NY. (Doka has disclosed no relevant financial relationships.) Objectives 1. Describe institutional, intuitive, blended, and dissonant patterns of grief. 2. Discuss the ways that each pattern can facilitate or complicate the illness and grieving process. 3. Identify and discuss pathways to grieving patterns including, gender, culture, cohort, and temperament, 4. Describe interventive techniques suitable for each pattern. Many individuals believe that if an individual does not show or share sadness or express other emotions in coping with illness or loss, that individual is not in touch with or is suppressing emotion. In fact, grief reactions are highly individual and varied. Many men, and women, may express their grief in more instrumental ways, showing grief in more cognitive or active manifestations while others may use a more intuitive or emotion-based approach. This session explores the different patterns or styles of grief, as they are expressed in illness or loss, emphasizing that each of these pattern has their own distinct advantages and disadvantages.
Vol. 43 No. 2 February 2012
Schedule With Abstracts
Clinicians would benefit from this session in two major ways. First, it challenges clinicians to move beyond affect to explore the many ways that individuals cope with loss. Second, the presentation offers specific interventive strategies that are effective with different patterns.
Social Media ¼ Public Health Christian T. Sinclair, MD FAAHPM, Kansas City Hospice, Kansas City, MO. (Sinclair has disclosed no relevant financial relationships.) Objectives 1. Demonstrate the growth of social media as an effective health communication platform. 2. Recognize opportunities for professionals and organizations to efficiently incorporate social media as a public health education tool. By now you have heard so much about social media you are probably wondering when it might go away. While it may evolve and the latest platform of choice may change, the foundational aspects of social mediadincluding freedom of speech, cross-pollination of ideas, and ease of sharing across multiple media toolsdwill remain. These aspects make social media a great tool to help shape the public perception about hospice, palliative care, opioids, dying, grief, and many other aspects of our daily practice. Have you ever felt tired of educating by the ones? Well here is your chance to make a big difference. You will leave this session inspired to give it a try and talk to your colleagues and CEO about what you can do to use social media to improve public health.
10:45e11:45 am
Concurrent Sessions An Unlikely Union: Palliative Care and Wellness (400) Gregg VandeKieft, MD MA, Providence St. Peter Hospital, Olympia, WA. Rebecca Hawkins, ARNP, St. Mary Medical Center, Walla Walla, WA. Cobie Whitten, PhD, Providence Regional Cancer System, Olympia, WA. (All authors listed above for this session have disclosed no relevant financial relationships with the following exception: Hawkins is on
367
the speakers’ bureau and received an honorarium from Novartis, Amgen, and Oncology Nursing Society.) Objectives 1. Discuss the role of palliative care as a component of cancer survivorship and chronic disease management. 2. Describe a high functioning model of collaboration between palliative care teams, primary care clinicians, and subspecialists across the continuum of care for patients with cancer and other chronic illnesses. 3. List common conditions warranting palliative care in cancer survivors and in selected chronic diseases, along with appropriate therapies. Many clinicians equate palliative care with endof-life care and consult palliative care teams only after transitioning from ‘‘curative’’ therapies to end-of-life care. Recent literature demonstrates numerous advantages when cancer patients with advanced stage disease receive palliative care from the onset of cancer diagnosis and throughout their illness spectrum. Less attention has been paid to the palliative care needs of cancer survivors or patients with other chronic diseases in every stage of their illness. Using cancer survivorship as a model, this session will explore the role of palliative care in chronic disease more broadly. The presenters will outline how principles from cancer survivorship and palliative care can be integrated within the care of other chronic diseases, such as neurological disease, renal, lung, or cardiac disease. They will review palliative care needs and treatment options throughout the continuum of care in chronic illness, including cancer survivorship. Models of collaboration between diseaseoriented subspecialists, primary care clinicians, and palliative care teams will be highlighted, including strategies to facilitate optimal transition from ‘‘active treatment’’ by subspecialists back to longitudinal care by primary care clinicians with ongoing palliative care support. Common symptom complexes in cancer survivorship and chronic disease will be presented, along with interventions that palliative care teams can provide to support referring clinicians. The presenters include a palliative care physician with comprehensive primary care experience, a palliative care nurse practitioner with an extensive background in oncology nursing, and a psycho-oncologist specializing in cancer